Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Annals of the New York Academy of Sciences|January 16, 2016
The development of lurasidone for bipolar depressionAntony Loebel, Jane Xu, Jay Hsu, et al.
Clinical Therapeutics|January 6, 2016
Lurasidone Dose Response in Bipolar Depression: A Population Dose-response AnalysisSunny Chapel, Yu-Yuan Chiu, Jay Hsu, et al.
Schizophrenia Research|January 15, 2022
Long-term safety and effectiveness of open-label lurasidone in antipsychotic-Naïve versus previously treated adolescents with Schizophrenia: A post-hoc analysisChristoph U Correll, Michael Tocco, Andrei Pikalov, et al.
General Hospital Psychiatry|August 16, 2017
Efficacy of lurasidone in the treatment of agitation: A post hoc analysis of five short-term studies in acutely ill patients with schizophreniaMichael H Allen, Leslie Citrome, Andrei Pikalov, et al.
BMC Psychiatry|February 25, 2014
Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophreniaGeorge Awad, Mariam Hassan, Antony Loebel, et al.
Neurology and Therapy|October 24, 2020
Long-Term Assessment of Lurasidone in Schizophrenia: Post Hoc Analysis of a 12-Month, Double Blind, Active-Controlled Trial and 6-Month Open-Label Extension StudyPreeya J Patel, Christian Weidenfeller, Andrew P Jones, et al.
BMC Psychiatry|June 2, 2016
Long-term health-related quality of life improvements among patients treated with lurasidone: results from the open-label extension of a switch trial in schizophreniaGeorge Awad, Daisy Ng-Mak, Krithika Rajagopalan, et al.
CNS Spectrums|April 7, 2016
Long-term safety and effectiveness of lurasidone in schizophrenia: a 22-month, open-label extension studyChristoph U Correll, Josephine Cucchiaro, Robert Silva, et al.
The Journal of Clinical Psychiatry|April 2, 2013
Effectiveness of lurasidone for patients with schizophrenia following 6 weeks of acute treatment with lurasidone, olanzapine, or placebo: a 6-month, open-label, extension studyStephen M Stahl, Josephine Cucchiaro, Doreen Simonelli, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 10, 2021
Efficacy and safety of lurasidone in adolescents and young adults with schizophrenia: A pooled post hoc analysis of double-blind, placebo-controlled 6-week studiesIsabella Costamagna, Fabrizio Calisti, Agnese Cattaneo, et al.
Pageof 2